A shadow market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Gaining Traction Online
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, physicians and chemists have cautions that the sale of what remains an unapproved medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.
Several professionals said the demand for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.
Regulatory Position and Enforcement
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate medicines, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.
Platform Reaction and Content Removal
According to the social media company, the platform has taken down violative material and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform safe and allocating resources in enhancing compliance measures.
Online Marketplace Activities
Research also found communities with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, glowing reviews and detailed instructions for mixing or administering at home.
Within minutes of entering one group, a seller shared WhatsApp details, where most transactions take place. The seller provided an instruction manual and promised delivery within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.
Product Details and Costs
Inside these communities, posts show dark colored packages with postal service labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how much time a injector should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering materials they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly significant medical dangers”.
